November 10, 2023 - Valneva SE, a specialty vaccine company, has announced that the U.S. Food and Drug
Administration (FDA) has approved Ixchiq®. Valneva’s single-dose
November 9, 2023 - Earlier onset of atrial fibrillation (AF) is associated with increased risk of developing
all-cause dementia, vascular dementia (VD), and Alzheimer disease (AD), according to a study
November 8, 2023 - Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved FruzaqlaTM (fruquintinib), an oral targeted therapy for adults with metastatic
November 8, 2023 - The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's
ZepboundTM (tirzepatide) injection, the first and only obesity treatment
November 1, 2023 - Phathom Pharmaceuticals, Inc. a biopharmaceutical company focused on developing
and commercializing novel treatments for gastrointestinal